Here are what the editors at HealthDay consider to be the most important developments in Radiology for March 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Doctors With Malpractice Claims More Likely to Leave Medicine
THURSDAY, March 28, 2019 (HealthDay News) — Physicians with one or more paid malpractice claims are more likely to leave practice or shift into smaller practice settings, according to a study published in the March 28 issue of the New England Journal of Medicine.
Abstract/Full Text (subscription or payment may be required)
FDA: Breast Density Must Be Reported to Women During Mammograms
WEDNESDAY, March 27, 2019 (HealthDay News) — Women with dense breasts who get mammograms must be told of their higher risk for breast cancer under new rules proposed Wednesday by the U.S. Food and Drug Administration.
Maltreatment in Childhood May Affect Course of Adult Depression
WEDNESDAY, March 27, 2019 (HealthDay News) — Early life stress caused by childhood maltreatment can alter brain structure, which may increase the risk for adverse disease courses in patients with major depression, according to a study published in the April issue of The Lancet Psychiatry.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Douglas County, Colorado, Ranked as Healthiest Community
TUESDAY, March 26, 2019 (HealthDay News) — The 2019 healthiest community in America is Douglas County, Colorado, according to a report published online March 26 by U.S. News & World Report, in conjunction with the Aetna Foundation.
Radiomic Features May Predict Response to Chemo in NSCLC
TUESDAY, March 26, 2019 (HealthDay News) — For patients with lung adenocarcinoma, radiomic texture features extracted from within and around the nodule on baseline computed tomography (CT) scans can predict response to chemotherapy, according to a study published online March 20 in Radiology: Artificial Intelligence.
2019 Residency Match Day Was Largest in History
MONDAY, March 25, 2019 (HealthDay News) — The 2019 Main Residency Match was the largest in history, with a record high of 38,376 applicants for 35,185 positions, according to 2019 Match Day results released by the National Resident Matching Program.
More Vascular Risk Factors Tied to Worse Brain Health
FRIDAY, March 22, 2019 (HealthDay News) — A higher number of vascular risk factors (VRFs) is associated with poorer brain health across gray and white matter macrostructure and microstructure, according to a study published online March 11 in the European Heart Journal.
Abstract/Full Text (subscription or payment may be required)
State Breast Density Notification Laws May Up Ultrasound Use
FRIDAY, March 22, 2019 (HealthDay News) — Dense breast notification (DBN) laws are associated with increased use of ultrasound and cancer detection only when notification of the possible benefits of supplemental screening is required, according to a study published online March 21 in the American Journal of Public Health.
Abstract/Full Text (subscription or payment may be required)
Digital Breast Tomosynthesis Can Reduce Benign Biopsy Rate
THURSDAY, March 21, 2019 (HealthDay News) — Digital breast tomosynthesis (DBT) can reduce the rate of benign biopsies without affecting cancer detection compared with full-field digital mammography (FFDM), according to a study published online March 19 in Radiology.
Pregnancy-Adapted Algorithm Avoids Diagnostic Imaging for PE
WEDNESDAY, March 20, 2019 (HealthDay News) — A pregnancy-adapted algorithm can safely avoid diagnostic imaging in a proportion of pregnant women with suspected pulmonary embolism, according to a study published in the March 21 issue of the New England Journal of Medicine.
Abstract/Full Text (subscription or payment may be required)
Breast Density Categorization Varies With Screening Modality
WEDNESDAY, March 20, 2019 (HealthDay News) — Breast Imaging Reporting and Data System (BI-RADS) breast density categorization may vary by screening mammographic modality, according to a study published online March 19 in Radiology.
Overall, Physicians Are Happy and Enjoy Their Lives
WEDNESDAY, March 20, 2019 (HealthDay News) — Overall, physicians are happy and enjoy their lives, according to the 2019 American Academy of Family Physicians (AAFP)/CompHealth Physician Happiness Survey published online March 19.
2019 AAFP/CompHealth Physician Happiness Survey
Average of 8.8 Inactive Ingredients Found in Oral Medications
MONDAY, March 18, 2019 (HealthDay News) — Oral forms of medications contain an average of 8.8 inactive ingredients, many of which could cause adverse reactions, according to a perspective piece published in the March 13 issue of Science Translational Medicine.
Abstract/Full Text (subscription or payment may be required)
Physician Burnout Rate Increased From 2014 to 2017
FRIDAY, March 15, 2019 (HealthDay News) — From 2014 to 2017, there was an increase in physician burnout, with early-career physicians being the most susceptible, according to a study published online March 15 in JAMA Network Open.
Head of National Cancer Institute Named Acting FDA Commissioner
WEDNESDAY, March 13, 2019 (HealthDay News) — The U.S. Food and Drug Administration will temporarily be overseen by the head of the National Cancer Institute when FDA Commissioner Scott Gottlieb, M.D., leaves the post next month.
Noncontrast Brain MRI Effective for Monitoring Multiple Sclerosis
WEDNESDAY, March 13, 2019 (HealthDay News) — For patients with multiple sclerosis (MS), use of a contrast-based agent at follow-up magnetic resonance imaging (MRI) does not change the diagnosis of interval disease progression, according to a study published online March 12 in Radiology.
CDC: Most Americans Report Excellent, Good Health
WEDNESDAY, March 13, 2019 (HealthDay News) — Most Americans report having excellent or good health and have a usual place to go for medical care, according to a report published March 13 for the National Health Interview Survey Early Release Program.
MRI Method That Measures Iron in Brain Shows Impact of Stroke
TUESDAY, March 12, 2019 (HealthDay News) — Higher values of R2* (the magnetic resonance transverse relaxation rate) found in the substantia nigra (SN) likely reflect greater iron content and are associated with worse long-term outcomes after stroke, according to a study published online March 12 in Radiology.
Retinal Microvascular Changes Identified in Alzheimer Disease
MONDAY, March 11, 2019 (HealthDay News) — Individuals with Alzheimer disease (AD) have changes in the retinal microvasculature in the superficial capillary plexus (SCP) compared with those with mild cognitive impairment (MCI) and controls, according to a study published online March 11 in Ophthalmology Retina.
Abstract/Full Text (subscription or payment may be required)
Chest CT May Be Better Than PET/CT for HNSCC Distant Metastasis Evaluation
MONDAY, March 11, 2019 (HealthDay News) — As distant metastasis (DM) in head and neck squamous cell carcinoma (HNSCC) is a rare event, computed tomography of the chest may be more cost-effective for evaluation, according to a study recently published in Oral Oncology.
Recall Down, Cancer Detection Up With Digital Breast Tomosynthesis
THURSDAY, March 7, 2019 (HealthDay News) — Digital breast tomosynthesis (DBT) is associated with lower recall and higher cancer detection rates than digital mammography (DM), according to research published online Feb. 28 in JAMA Oncology.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
FDA Commissioner Dr. Scott Gottlieb Resigns
TUESDAY, March 5, 2019 (HealthDay News) — In what probably came as a surprise to many, U.S. Food and Drug Administration Commissioner Scott Gottlieb, M.D., announced his resignation on Tuesday. Gottlieb is leaving the FDA because he wants to spend more time with his wife and three young daughters — twins aged 9 and a 5-year-old — one official said. He currently commutes each week from the family home in Connecticut to his Washington, D.C., office.
Stereotactic Body RT Promising for Low-, Intermediate-Risk PCa
TUESDAY, March 5, 2019 (HealthDay News) — In men with low-risk and intermediate-risk prostate cancer, stereotactic body radiotherapy is associated with low rates of severe toxic events and high rates of biochemical control, according to a study published online Feb. 8 in JAMA Network Open.
Copyright © 2019 ScoutNews, LLC. All rights reserved.
